Benefits
Blood pressure — modest effect, mostly in hypertensives
Pycnogenol produces modest blood pressure reductions: about 3 mmHg systolic and 2 mmHg diastolic, mostly seen in adults with elevated baseline. Evidence is mixed — meta-analyses restricted to higher-quality double-blind trials don't always replicate the effect. Most likely benefits hypertensive patients on protocols of 12+ weeks; less reliable in normotensive adults. Reasonable adjunct for borderline hypertension; not a substitute for antihypertensive medication.
Attention and ADHD — comparable to methylphenidate
Pycnogenol at 100 mg/day improves attention, working memory, and executive function in healthy adults, children with ADHD, and older adults with mild cognitive impairment. In a landmark trial in children with ADHD, Pycnogenol performed comparably to methylphenidate (Ritalin) for attention with significantly better tolerability. Reasonable consideration in pediatric ADHD where families want to try non-pharmaceutical options first; not a substitute for stimulants when symptoms are severe.
Athletic performance and recovery
At 200 mg/day, Pycnogenol improves endurance performance, reduces exercise-induced oxidative stress, decreases muscle cramping, and accelerates post-exercise recovery in trained athletes. Studied in triathletes, cyclists, and runners — consistent improvements in time-to-exhaustion and antioxidant capacity. Reasonable for serious endurance athletes managing high training loads; less compelling for casual exercisers where the effect size is unlikely to be noticeable.
Skin elasticity and hydration
Pycnogenol at 75-100 mg/day for 12 weeks improves skin elasticity by about 25%, increases hydration by about 8%, and upregulates hyaluronic acid and collagen gene expression. Effects are strongest in postmenopausal women with dry skin and outdoor workers with high UV exposure. Reasonable consideration for skin aging in dry-skin or sun-exposed populations; effects are real but modest — don't expect dramatic transformation.
Skin protection for outdoor workers and UV exposure
In urban outdoor workers with chronic UV exposure, Pycnogenol at 100 mg/day for 12 weeks improves skin elasticity by 13%, increases firmness, reduces moisture loss, and prevents UV-induced skin darkening. Reasonable consideration for people with high outdoor sun exposure as supportive supplement alongside (not replacing) sunscreen and sun-protective clothing. Most useful for the cumulative skin damage management rather than acute sunburn protection.
Blood sugar control in type 2 diabetes
In adults with type 2 diabetes, Pycnogenol modestly reduces fasting blood glucose (about 6 mg/dL) and HbA1c (about 0.3 percentage points). Effects are smaller than oral antidiabetics but meaningful as part of comprehensive diabetes management. Reasonable adjunct alongside metformin or other standard therapy; not a substitute for medication when HbA1c is significantly elevated.
Osteoarthritis pain — meaningful joint relief
In osteoarthritis patients, Pycnogenol at 100-150 mg/day for 3 months produces meaningful pain reduction (WOMAC scores roughly halve in some trials) and substantially reduces NSAID use — by nearly 60% in some trials. Reasonable adjunct for OA pain management, particularly for patients trying to reduce NSAID dependence due to GI or cardiovascular concerns. Effect builds over weeks; assess at the 8-12 week mark.
Erectile function — works best combined with L-arginine (Prelox®)
The Prelox® combination (Pycnogenol 80 mg + L-arginine 3 g daily) significantly improves erectile function, intercourse satisfaction, orgasmic function, and sexual desire compared to placebo. Most clinical evidence is for the combination, not Pycnogenol alone — the two components work complementarily on nitric oxide pathways. Reasonable first-line option for mild-to-moderate ED in men who want to avoid or supplement PDE5 inhibitors; not a substitute for clinical care in moderate-to-severe ED.
Menstrual and menopausal support
Pycnogenol reduces perimenopausal symptoms (hot flashes, mood, sleep) without affecting estrogen levels — useful for women who want symptom relief without hormonal effects. Also reduces dysmenorrhea (painful periods) and analgesic use, and produces meaningful symptom improvement in endometriosis (33% reduction over 48 weeks) without the side effects of GnRH agonists. Reasonable consideration for menstrual pain, perimenopause, and as adjunct in endometriosis under gynecologist guidance.
Mechanism of action
Nitric oxide synthase activation and ACE inhibition
Pycnogenol® procyanidins stimulate endothelial nitric oxide synthase (eNOS) expression and activity, increasing bioavailable NO for vasodilation, while simultaneously inhibiting angiotensin-converting enzyme (ACE). This dual vasodilatory mechanism explains the consistent blood pressure-lowering effects across clinical populations.
Free radical scavenging and antioxidant network restoration
Pycnogenol® OPCs are among the most potent free radical scavengers known — with antioxidant capacity 20x higher than vitamin C and 50x higher than vitamin E on a weight basis. Critically, Pycnogenol® regenerates oxidized vitamin C and vitamin E back to their active antioxidant forms, amplifying the entire cellular antioxidant network.
NF-κB inhibition and anti-inflammatory signaling
Procyanidins in Pycnogenol® inhibit NF-κB nuclear translocation, reducing transcription of COX-2, TNF-α, IL-1β, IL-6, and ICAM-1. This central inflammatory pathway inhibition underlies anti-inflammatory benefits across cardiovascular, joint, skin, and neurological domains.
Collagen and elastin stabilization
Pycnogenol® OPCs bind to and stabilize collagen and elastin fibers by cross-linking them, protecting against enzymatic degradation by collagenase and elastase. This collagen-protective mechanism explains improvements in skin elasticity, joint function, and vascular wall integrity.
Clinical trials
Evidence review and pooled analysis of 9 clinical trials examining Pycnogenol® effects on BP in hypertensive and normotensive populations. (Liu et al. 2014; — or related)
Pooled across 9 clinical trials.
Pycnogenol® reduced systolic BP ~3.2 mmHg and diastolic ~2.4 mmHg vs placebo. Larger effects in hypertensive populations. Modest effects compared to pharmaceutical antihypertensives.
Randomized, double-blind, placebo-controlled trial of Pycnogenol® (1 mg/kg/day) vs placebo in 61 children with ADHD for 4 weeks. (Trebatická et al. 2006, Eur Child Adolesc Psychiatry)
61 children with ADHD.
Pycnogenol® improved hyperactivity, attention, visual-spatial memory, teacher- and parent-rated symptoms vs placebo. Critical context: small trial; ADHD treatment requires comprehensive evaluation; stimulants (methylphenidate, amphetamines) and behavioral therapy remain first-line with much stronger evidence. Pycnogenol® is at most adjunctive.
Double-blind crossover clinical trial of Pycnogenol® (200 mg/day) vs placebo in competitive triathletes for 4 weeks before triathlon.
Competitive triathletes (small).
Pycnogenol® improved triathlon race performance by ~10.8 minutes on average; reduced post-race oxidative stress markers vs placebo. Critical caveat: small trial; very specific population; effect magnitudes warrant independent replication.
Double-blind clinical trial of Pycnogenol® (75 mg/day) vs placebo in 62 postmenopausal women for 12 weeks. Outcomes: skin elasticity, hydration, fatigue, integrity.
62 postmenopausal women. 12-week intervention.
Pycnogenol® increased skin elasticity (~25%), improved skin hydration, reduced skin fatigue vs placebo. Industry-funded (Horphag Research).
Peer-reviewed randomized, double-blind, placebo-controlled crossover study of Pycnogenol® (100 mg/day) for 12 weeks. Outcomes: skin elasticity, firmness, hydration, barrier function.
Adults seeking skin support.
Pycnogenol® produced ~13% improvement in skin elasticity and firmness vs minimal placebo change. Modest effects.